|View printer-friendly version|
|ExactTarget Prices Initial Public Offering|
INDIANAPOLIS--(BUSINESS WIRE)--ExactTarget, a global provider of cross-channel interactive marketing solutions, announced today the pricing of its initial public offering of 8,500,000 shares of common stock at a price to the public of $19.00 per share. The shares are expected to begin trading on The New York Stock Exchange on March 22, 2012 under the symbol "ET". All of the shares being sold in the offering are being sold by ExactTarget. The underwriters have a 30-day option to purchase up to an additional 1,275,000 shares of common stock from ExactTarget to cover over-allotments, if any.
J.P. Morgan, Deutsche Bank Securities and Stifel Nicolaus Weisel are acting as joint book-runners for the offering, with RBC Capital Markets, Pacific Crest Securities, Canaccord Genuity and Raymond James acting as co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 21, 2012. This offering is being made solely by means of a prospectus, copies of which may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at (866) 803-9204; Deutsche Bank Securities Inc., Attn: Prospectus Department, Harborside Financial Center, 100 Plaza One, Jersey City, NJ 07311-3988, by telephone at (800) 503-4611, or by e-mail at email@example.com; or Stifel Nicolaus Weisel, One Montgomery Street, Suite 3700, San Francisco, California 94104, or by telephone at (415) 364-2720.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.Contacts
|Safe Harbor Statement|
|The materials contained on this website include information as of the date noted thereon and may contain certain projections or other forward-looking statements regarding future events or the future performance of the company. Various factors, including risks and uncertainties referred to in the 10Ks, 10Qs and other reports ExactTarget, Inc. periodically files with the SEC, could cause our actual results to differ materially from those indicated by our projections or other forward-looking statements and we caution that we do not undertake to update these projections or forward-looking statements. The materials may also contain disclosure of non-GAAP financial measures. A reconciliation of these financial measures to the most directly comparable GAAP financial measure can be found in the related presentation or elsewhere on this website.|